AREV NanoTec Brands Inc
AREV Life Sciences Global Corp. operates as an early-stage life science discovery company in Canada. It is involved in the extraction of compounds for consumption and topical use; clinical nutrition business; and Medicine Merchant, a technology platform. The company's pipeline products include SUS-TAINN, a superior utility supplementation therapeutic agent for indicated nutritional needs; and RES… Read more
AREV NanoTec Brands Inc (AREVF) - Total Assets
Latest total assets as of September 2023: $213.29K USD
Based on the latest financial reports, AREV NanoTec Brands Inc (AREVF) holds total assets worth $213.29K USD as of September 2023.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
AREV NanoTec Brands Inc - Total Assets Trend (2008–2022)
This chart illustrates how AREV NanoTec Brands Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
AREV NanoTec Brands Inc - Asset Composition Analysis
Current Asset Composition (December 2022)
AREV NanoTec Brands Inc's total assets of $213.29K consist of 26.4% current assets and 73.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0.0% |
| Accounts Receivable | $48.77K | 19.3% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2008–2022)
This chart illustrates how AREV NanoTec Brands Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AREV NanoTec Brands Inc's current assets represent 26.4% of total assets in 2022, a decrease from 87.7% in 2008.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2022, down from 24.3% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 6.0% in 2008.
- Asset Diversification: The largest asset category is accounts receivable at 19.3% of total assets.
AREV NanoTec Brands Inc Competitors by Total Assets
Key competitors of AREV NanoTec Brands Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
AREV NanoTec Brands Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - AREV NanoTec Brands Inc generates 0.19x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - AREV NanoTec Brands Inc is currently not profitable relative to its asset base.
AREV NanoTec Brands Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.05 | 0.11 | 0.70 |
| Quick Ratio | 0.05 | 0.09 | 1.44 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-1.31 Million | $ -1.07 Million | $ -226.45K |
AREV NanoTec Brands Inc - Advanced Valuation Insights
This section examines the relationship between AREV NanoTec Brands Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.60 |
| Latest Market Cap to Assets Ratio | 0.06 |
| Asset Growth Rate (YoY) | -59.4% |
| Total Assets | $252.63K |
| Market Capitalization | $15.88K USD |
Valuation Analysis
Below Book Valuation: The market values AREV NanoTec Brands Inc's assets below their book value (0.06 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: AREV NanoTec Brands Inc's assets decreased by 59.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for AREV NanoTec Brands Inc (2008–2022)
The table below shows the annual total assets of AREV NanoTec Brands Inc from 2008 to 2022.
| Year | Total Assets | Change |
|---|---|---|
| 2022-12-31 | $252.63K | -59.42% |
| 2021-12-31 | $622.57K | -51.25% |
| 2020-12-31 | $1.28 Million | +45.22% |
| 2019-12-31 | $879.42K | +65.86% |
| 2018-12-31 | $530.22K | -68.04% |
| 2017-12-31 | $1.66 Million | +108.91% |
| 2016-12-31 | $794.04K | +4479.49% |
| 2015-12-31 | $17.34K | +394.98% |
| 2014-12-31 | $3.50K | -93.37% |
| 2013-12-31 | $52.80K | -36.73% |
| 2012-12-31 | $83.47K | -40.46% |
| 2011-12-31 | $140.17K | +76.11% |
| 2010-12-31 | $79.59K | -23.85% |
| 2009-12-31 | $104.53K | -68.02% |
| 2008-12-31 | $326.84K | -- |